Experimental evidence indicates that IGF1R signaling supports tumor growth and survival predominantly through stimulation of the phosphoinositide 3-kinase (PI3K), an enzyme linked to cell growth and proliferation/Akt cell survival pathway [6–9]. Here, AKT1 is linked to neoplasm.